144 related articles for article (PubMed ID: 2643702)
1. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
Mangino MJ; Brunt EM; Von Doersten P; Anderson CB
J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane synthesis inhibition and renal allograft function.
Anderson C; Jendrisak M; Brunt E; Tobimatsu M; Murphy M; Sicard G; Mangino M
Transplant Proc; 1989 Feb; 21(1 Pt 1):1161-4. PubMed ID: 2650085
[TBL] [Abstract][Full Text] [Related]
3. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
Grauer GF; Greco DS; Behrend EN; Fettman MJ; Mani I; Getzy DM; Reinhart GA
Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
[TBL] [Abstract][Full Text] [Related]
4. In vivo prostanoid formation during acute renal allograft rejection.
Tönshoff B; Busch C; Schweer H; Schärer K; Seyberth HW
Nephrol Dial Transplant; 1993; 8(7):631-6. PubMed ID: 8396748
[TBL] [Abstract][Full Text] [Related]
5. Functional role of thromboxane production by acutely rejecting renal allografts in rats.
Coffman TM; Yarger WE; Klotman PE
J Clin Invest; 1985 Apr; 75(4):1242-8. PubMed ID: 3886703
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin synthesis associated with renal allograft rejection in the dog.
Tannenbaum JS; Anderson CB; Sicard GA; McKeel DW; Etheredge EE
Transplantation; 1984 May; 37(5):438-43. PubMed ID: 6374997
[TBL] [Abstract][Full Text] [Related]
7. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
[TBL] [Abstract][Full Text] [Related]
8. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
[TBL] [Abstract][Full Text] [Related]
9. Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis.
Longhofer SL; Frisbie DD; Johnson HC; Culham CA; Cooley AJ; Schultz KT; Grauer GF
Am J Vet Res; 1991 Mar; 52(3):480-7. PubMed ID: 1827969
[TBL] [Abstract][Full Text] [Related]
10. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
[TBL] [Abstract][Full Text] [Related]
12. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
13. Eicosanoid synthesis inhibition and renal allograft function during acute rejection.
Mangino MJ; Jendrisak MD; Brunt E; Anderson CB
Transplantation; 1988 May; 45(5):902-7. PubMed ID: 3130697
[TBL] [Abstract][Full Text] [Related]
14. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
[TBL] [Abstract][Full Text] [Related]
15. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
16. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
[TBL] [Abstract][Full Text] [Related]
17. Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts.
Ruiz P; Coffman TM; Klotman PE; Sanfilippo F
Transplantation; 1989 Oct; 48(4):660-6. PubMed ID: 2799920
[TBL] [Abstract][Full Text] [Related]
18. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
Abels BC; Branch RA; Sabra R
J Pharmacol Exp Ther; 1993 Mar; 264(3):1285-92. PubMed ID: 8450463
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
Patrignani P; Filabozzi P; Catella F; Pugliese F; Patrono C
J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
[TBL] [Abstract][Full Text] [Related]
20. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity.
Smith SR; Kubacki VB; Rakhit A; Martin LL; Schaffer AV; Jasani MK; Hefty DJ; Johnston T; Cannon C; Bennett WM
Transplantation; 1993 Dec; 56(6):1422-6. PubMed ID: 8279014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
